.jpg)
Sadly, many women of childbearing age who has cancer, and are undergoing chemotherapy, do not know that their ability to conceive can be severely hampered, because of the drugs administered in this process. As a result, women in this regard are encouraged to have this conversation with their doctor.
There is renewed reasons to hope though, that they still will be able to conceive, as Northwestern Medicine
scientists have now found a way to prevent the demise of immature ovarian eggs
due to chemotherapy.
Read more in this regard, by following the link
below:-
From the article:
"This research advances the efforts to find a medical treatment to protect the fertility and hormone health of girls and young women during cancer treatment, " said So-Youn Kim, the lead investigator and a postdoctoral fellow in the laboratory of Teresa Woodruff, chief of fertility preservation at Northwestern University Feinberg School of Medicine.
Adding imatinib mesylate to the drug cisplatin blocks the action of a protein that triggers a cascade of events resulting in death of the immature eggs. Kim discovered the protein that triggers the oocyte's ultimate death is Tap63.
Previous research suggested that imatinib is a fertility-protecting drug against cisplatin, but reports of the drug's effectiveness have been contradictory, Kim said. Her research confirms its effectiveness in an animal model."
No comments:
Post a Comment